Wednesday, 11 May 2022
GCAT project joins IMPACTt2D consortium!
Informative scientific session on the role of GCAT in IMPACTt2D and its collaboration with Hospital Clínic de Barcelona
Last Wednesday, May 11th, the scientific director of GCAT, Rafael de Cid, communicated the role of GCAT in the -IMPACTt2D project, in close collaboration with other members of the consortium, such as the endocrinology service of the Hospital Clínic de Barcelona, led by Dr. Jesús Blanco. This project is focused on the development and implementation of genomic strategies for the development of precision medicine in Type 2 Diabetes.
Related Links
